Date of first VCS test:  Tue Jan 7 12:44:06 2014 (EST)
Date of most recent VCS test:  Wed Jun 20 21:58:21 2018 (EDT)
Time site in operation:  1625.4 days

Tests with POSITIVE results (suggesting neurotoxin exposure is likely):  74.6%
Tests with NEGATIVE results (suggesting neurotoxin exposure is unlikely):  25.4%


Percentage of VCS test takers responding to at least 1 survey question:  76%

Percentage of VCS test takers self-rating their overall health on a scale of 1-10 (10 being highest/best):  75.4%
   Average self-rated overall health among all respondents:  5.77
   Average self-rated overall health among respondents with POSITIVE test results:  5.68
   Average self-rated overall health among respondents with NEGATIVE test results:  6.04

Percentage of VCS test takers who responded regarding recent mold exposure or suspected mold exposure:  74.7%
   Percentage reporting recent mold exposure or suspected mold exposure:  59.7%
      With POSITIVE test results:  76%
      With NEGATIVE test results:  24%
   Percentage reporting NO recent mold exposure or suspected mold exposure:  40.3%
      With POSITIVE test results:  72.1%
      With NEGATIVE test results:  27.9%

Percentage of VCS test takers who responded regarding mold illness diagnosis:  44.6%
   Percentage reporting mold illness diagnosis:  20.7%
      With POSITIVE test results:  75.1%
      With NEGATIVE test results:  24.9%
   Percentage reporting NO mold illness diagnosis:  79.3%
      With POSITIVE test results:  76.1%
      With NEGATIVE test results:  23.9%

Percentage of VCS test takers who responded regarding exposures to other neurotoxins:  74%
   Percentage reporting exposure to other neurotoxins:  37%
      With POSITIVE test results:  75.3%
      With NEGATIVE test results:  24.7%
   Percentage reporting NO exposure to other neurotoxins:  63%
      With POSITIVE test results:  73.8%
      With NEGATIVE test results:  26.2%

Percentage of VCS test takers who responded regarding diagnosis with exposure to other neurotoxins:  27.5%
   Percentage reporting diagnosis with exposure to other neurotoxins:  29.8%
      With POSITIVE test results:  74.1%
      With NEGATIVE test results:  25.9%
   Percentage reporting NO diagnosis with exposure to other neurotoxins:  70.2%
      With POSITIVE test results:  75.3%
      With NEGATIVE test results:  24.7%

Percentage of VCS test takers who responded regarding other conditions involving neurological function:  74%
   Percentage reporting suffering from a condition involving neurological function:  28.3%
      With POSITIVE test results:  75.2%
      With NEGATIVE test results:  24.8%
   Percentage reporting suffering from NO condition involving neurological function:  71.7%
      With POSITIVE test results:  74.1%
      With NEGATIVE test results:  25.9%